Clinical Trial

I.V Papavrine for Labor Induction in Term PROM

Name: I.V Papavrine for Labor Induction in Term PROM — clinical trial record (NCT07517796)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

This prospective randomized controlled trial aims to evaluate whether intravenous administration of papaverine 12 hours after term PROM reduces the interval from membrane rupture to delivery and improves maternal and neonatal outcomes. Researchers will compare drug papaverine to a placebo

Trial Details

NCT Number	NCT07517796
Lead Sponsor	Western Galilee Hospital-Nahariya
Conditions	Premature Rupture of Membranes
Enrollment	110 participants
Start Date	2025-10-22
Primary Completion	2027-10-22 (estimated)
Study Completion	2027-10-22 (estimated)
Updated on ClinicalTrials.gov	2026-04-08